Transcripts Arrowhead Pharmaceuticals, Inc.
Equities
ARWR
US04280A1007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.87 USD | +0.06% |
|
+5.83% | +266.33% |
| 12-02 | Arrowhead Pharmaceuticals Gets FDA Breakthrough Tag for Triglyceride Drug | MT |
| 12-02 | Arrowhead Pharmaceuticals receives FDA breakthrough therapy designation for plozasiran | RE |
Transcripts
Search
11-28 | ||
11-25 | ||
11-19 | ||
09-10 | ||
09-09 | ||
09-05 | ||
09-03 | ||
08-08 | ||
06-09 | ||
05-14 | ||
05-12 | ||
02-10 | ||
11-26 | ||
11-12 | ||
07/10/24 | ||
03/09/24 | ||
14/08/24 | ||
08/08/24 | ||
16/07/24 | ||
25/06/24 | ||
12/06/24 | ||
23/05/24 | ||
16/05/24 | ||
09/05/24 | ||
06/02/24 |
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition